The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 2, 2012, Pages 122-127

  Urbonas, Vincas ^a   Eidukaite, Audrone ^a   Tamuliene, Indre ^b  

^a National Research Institute   (Lithuania)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

cancer; febrile neutropenia; interleukin 6; interleukin 8

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 7;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; BLOOD CULTURE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE MARKER; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFANT; MALE; MALIGNANT NEOPLASTIC DISEASE; PREDICTION; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BACTEREMIA; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HUMANS; INFANT; INTERLEUKIN-6; INTERLEUKIN-8; MALE; NEOPLASMS; NEUTROPENIA; SEPSIS;

EID: 84857888083     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3182446a60     Document Type: Article

References (38)

1. Ben Abraham R, Toren A, Ono N, et al. Predictors of outcome in pediatric intensive care units of children with malignancies. J Pediatr Hematol Oncol. 2002;24:23-26.
2. Crokaert F. Febrile neutropenia in children. Int J Antimicrob Agent. 2000;16:173-177.
3. Bodey GP. Infections in cancer patients. Cancer Treat Rev. 1975;2:89-128.
4. Hann I, Viscoli C, Paesmans M, et al. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies. Br J Haematol. 1997;99:580-588.
5. Ariffin H, Ai CL, Lee CL, et al. Cefepime monotherapy for treatment of febrile neutropenia in children. J Pediatr Child Health. 2006;42:781-784.
6. Santolaya ME, Villarroel M, Avendano LF, et al. Discontinuation of antimicrobial therapy for febrile neutropenic children with cancer: A prospective study. Clin Infect Dis. 1997;25: 92-97.
7. Te Poele EM, Tissing WJE, Kamps WA, et al. Risk assessment in fever and neutropenia in children with cancer: What did we learn? Crit Rev Oncol Hematol. 2009;72:45-55.
8. Sleijfer S, Vujaskovic Z, Limburg PC, et al. Induction of tumor necrosis factor-alpha as a cause of bleomycin-related toxicity. Cancer. 1998;82:970-974.
9. Rose MS, Bateman DN. Pyrexia with cytosine arabinose. Br Med J. 1972;4:115.
10. Hughes WT, Armstrong D, Bodey GP, et al. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis. 2002;34:730-751.
11. Lau RC, Doyle JJ, Freedman MH, et al. Early discharge of pediatric febrile neutropenic cancer patients by substitution of oral for intravenous antibiotics. Pediatr Hematol Oncol. 1994;1:417-421.
12. Katz JS, Mustafa MM, Bash RO, et al. Value of C-reactive protein determination in the diagnostic evaluation of the febrile, neutropenic child with cancer. Pediatr Infect Dis J. 1992;11:708-712.
13. Heney D, Lewis IJ, Evans SW, et al. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis. 1992;165:886-890.
14. Bruserud O, Akselen PE, Berghein J, et al. Serum concentrations of E-selectin, P-selectin, ICAM-I and interleukin-6 in acute leukaemia patients with chemotherapy-induced leucopenia and bacterial infections. Brit J Haematol. 1995;91:394-402.
15. Abbas AK. Cytokines. In: Abbas AK, Lichtman AH, Pillai S, eds. Cellular and Molecular Immunology. 6th ed. Philadelphia: Saunders Elsevier; 2010:267-301.
16. Hippenstiel S, Soeth S, Kella B, et al. Rho proteins and the p38-MAPK pathway are important mediators for LPS-induced interleukin-8 expression in human endothelial cells. Blood. 2000;95:3044-3051.
17. Mukaida N. Pathophysiological roles of interleukin-8/CXCL-8 in pulmonary diseases. Am J Physiol Lung Cell Mol Physiol. 2003;284:L566-L577.
18. Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 1992; 258:1798-1801.
19. Feugate JE, Li Q, Wong L, et al. The CXC chemokine cCAF stimulates differentiation fibroblasts into myofibroblasts and accelerates wound closure. J Cell Biol. 2002;156:161-172.
20. Takata H, Tomiyama H, Fujiwara M, et al. Cutting edge: Expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol. 2004;173:2231-2235.
21. Strieter RM, Polverini PJ, Arenberg DA, et al. Role of C-X-C chemokines as regulators of angiogenesis in lung cancer. J Leukoc Biol. 1995;57:752-762.
22. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
23. Talcot JA. Out-patient management of febrile neutropenia. J Antimicrob Agents. 2000;16:169-171.
24. Klassen RJ, Goodman TR, Pham B, et al. "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol. 2000;18:1012-1019.
25. Bodey GP, Buckley M, Sathe YS, et al. Risk factors assessment in febrile neutropenia. Int J Antimicrob Agents. 2000;16: 107-111.
26. De Bont ESJM, Vellenga E, Swaanenburg JCJM, et al. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia. Brit J Haematol. 1999;107:375-380.
27. Stryjewski GR, Nylen ES, Bell MJ, et al. Interleukin-6, interleukin-8 and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med. 2005;6:129-135.
28. Soker M, Colpan L, Ece A, et al. Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8 and TNF-alpha in febrile children with cancer and neutropenia. Med Oncol. 2001;18:51-57.
29. Santolaya ME, Alvarez AM, Carmen LA, et al. Predictors of severe sepsis not clinically apparent during the first twenty-four hours of hospitalization in children with cancer, neutropenia and fever. A prospective, multicenter trial. Pediatr Infect Dis J. 2008;27:538-543.
30. Diepold M, Noellke P, Duffner U, et al. Performance of interleukin-6 and interleukin-8 serum levels in pediatric oncology patients with neutropenia and fever for the assessment of low-risk. BMC Infect Dis. 2008;8:28.
31. Persson L, Engervall P, Magnuson A, et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis. 2004; 36:365-371.
32. Riikonen P, Saarinen UM, Teppo AM, et al. Cytokine and acute phase reactant levels in serum of children with cancer admitted for fever and neutropenia. J Infect Dis. 1992;166: 432-436.
33. Schonbohn H, Schuler M, Kolbe K, et al. Plasma levels of IL- 1, TNF alpha, IL-6, IL-8, G-CSF and IL-1 RA during febrile neutropenia: Results of prospective study in patients undergoing chemotherapy for acute myelogenous leukemia. Ann Hematol. 1995;71:161-168.
34. Lehrnbecher T, Fleischhack G, Hanisch M, et al. Circulating levels and promoter polymorphisms of interleukins-6 and 8 in pediatric cancer patients with fever and neutropenia. Haematologica. 2004;89:232-236.
35. Lehrnbecher T, Venzon D, de Haas M, et al. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III and mannose-binding protein in febrile children with cancer and neutropenia. Clin Infect Dis. 1999;29:414-419.
36. Engel A, Steinbach G, Kern P, et al. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: Comparison with Interleukin-8. Scand J Infect Dis. 1999; 31:185-189.
37. Hessle CC, Andersson B, Wold AE. Gram-positive and Gramnegative bacteria elicit different patterns of pro-inflammatory cytokines in human monocytes. Cytokine. 2005;30:311-318.
38. Skovbjerg S, Martner A, Hynsjo L, et al. Gram-positive and Gram-negative bacteria induce different patterns of cytokine production in human mononuclear cells irrespective of taxonomic relatedness. J Interferon Cytokine Res. 2010;30:23-32.